$4.630
+0.975 (+21.05%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GLMD por análisis de gráficos similares
Alphio's GLMD stock price prediction model matches the current Galmed Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.58 (-1.17%). The 1-week path is $4.68 (+1.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Galmed Pharmaceuticals Ltd?
Galmed Pharmaceuticals Ltd is not a good buy right now due to its declining stock performance and negative financial indicators. The current price is $3.88, with a year-to-date change of -41.06% and a one-year change of -64.60%. Additionally, the company reported a last earnings EPS of -2.86, indicating ongoing losses. The RSI is at 33.289, suggesting the stock is oversold but may not recover soon given the persistent negative net income figures, such as -4,818,000 USD in Q4 2025. The main risk is the continued negative earnings trend, which has resulted in a forward P/E ratio of 0, indicating no earnings growth is expected in the near future.
GLMD cerró en $4.63 el Wednesday, tras subir +21.05%
Galmed Pharmaceuticals Ltd (GLMD) last closed at $4.63, gaining +21.05%. These facts feed the 1-day and 1-week GLMD price prediction above.
Consenso de analistas
Galmed Pharmaceuticals Ltd (GLMD): 5 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Galmed Pharmaceuticals Ltd (GLMD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GLMD, ordenadas por similitud.
Análisis de estacionalidad de GLMD
Historically the probability of a positive November return for GLMD is 0.00%. January offers the highest probability of a positive month at 26.23%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GLMD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $2.02 | $2.21 | $2.36 | -52.27% |
| Dec 2026 | $2.00 | $2.21 | $2.24 | -52.27% |
En 2026, se proyecta que Galmed Pharmaceuticals Ltd (GLMD) oscile entre $2.00 y $2.36.
Previsión mensual de Galmed Pharmaceuticals Ltd para 2026
En Nov de 2026, se proyecta que Galmed Pharmaceuticals Ltd promedie $2.21, con un mínimo de $2.02 y un máximo de $2.36.
En Dec de 2026, se proyecta que Galmed Pharmaceuticals Ltd promedie $2.21, con un mínimo de $2.00 y un máximo de $2.24.
Artículos relacionados
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.